Tag: neurological health

Pentadecapeptide BPC 157 Counteracts L-NAME-Induced Catalepsy: BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Acute and Chronic Models Resembling ‘Positive-Like’ Symptoms of Schizophrenia

This 2020 preclinical study investigated the effects of BPC 157, a stable gastric pentadecapeptide, on L-NAME-induced catalepsy in rat models mimicking ‘positive-like’ symptoms of schizophrenia. L-NAME, a nitric oxide synthase inhibitor, induces catalepsy by disrupting nitric oxide (NO) signaling, which is implicated in schizophrenia pathophysiology. The study found that BPC

Read More »

The Combined Antioxidant Effects of N-Acetylcysteine, Vitamin D3, and Glutathione from the Intestinal-Neuronal In Vitro Model

This in vitro study examines the combined antioxidant effects of N-Acetylcysteine (NAC), Vitamin D3, and Glutathione on intestinal and neuronal barriers. The results demonstrated that this combination effectively crossed both barriers and showed significant neurological benefits, including a 10.5% reduction in inflammation, a 20.4% improvement in cell myelination, and an

Read More »

The neurobiology of acetyl-L-carnitine

This systematic review examines the neurobiological effects of acetyl-L-carnitine (ALC), a derivative of L-carnitine, focusing on its role in neurotransmitter modulation, neuroprotection, and cognitive enhancement. The review suggests that ALC has the potential to influence neurotransmitter systems, provide neuroprotection, and improve cognitive functions, making it potentially useful in treating neurological

Read More »